About PECA Labs
PECA Labs is a Healthcare company based in Pittsburgh (United States) founded in 2011. It operates as a pediatric cardiac surgical devices are developed for congenital heart defects. PECA Labs has raised $22.56 million across 12 funding rounds from investors including HHS, Innovation Works and BlueTree Allied Angels. PECA Labs offers products and services including exGraft, exGraft II, OKAPI, MASA Valve, and STEALTH. Its focus areas include Life Sciences, Pediatrics, Medical Devices and Therapeutics. Its legal entity is PECA Labs, Inc. Its competitors include Xeltis, Occlutech, Endonovo Therapeutics, Bolder Surgical and Coherex and 3 more; 7 of its 8 listed competitors have raised funding.
Company details
PECA Labs was founded in 2011 and is based in Pittsburgh, United States. Focus is placed on the medical device sector, specifically pediatric cardiology. Operations involve the creation of synthetic valved conduits, such as the MASA valve made from ePTFE for right ventricular outflow tract reconstruction. A valved RV-PA shunt is also under development to treat hypoplastic left heart syndrome and mitigate risks associated with the Norwood Procedure.
- Headquarters Pittsburgh, United States
- SectorsHealthcare
- Website pecalabs.com
- Social LinkedIn Facebook
- Legal Name Peca Labs, Inc.
- Total Equity Funding$22.56M (USD)
in 12 rounds
- Latest Funding Round$2.65M (USD), Series B
Nov 2025
- InvestorsHHS
& 2 more
Products & Services of PECA Labs
PECA Labs offers a comprehensive portfolio of products and services, including exGraft, exGraft II, OKAPI, MASA Valve, and STEALTH.
Provides next-generation grafts with radiopaque features for advanced visualization.
Offers customizable, expandable grafts for improved anatomical matching.
Delivers anti-thrombogenic grafts with bio-inert surfaces to reduce complications.
Features polymeric conduit for pulmonary reconstruction in clinical trials.
Includes transcatheter valve with slim delivery for enhanced performance.
Funding Insights of PECA Labs
PECA Labs has successfully raised a total of $22.56M across 12 strategic funding rounds. The most recent funding activity was a Series B round of $2.65 million completed in November 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $22.56M
- Total Rounds 12
- Last Round Series B — $2.65M
- First Round $250,000
(Aug 2013)
- Investors Count 3
Latest 10 of 12 funding rounds of PECA Labs with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov 2025 | $2.65M | Series B | – | – | – |
| Dec 2024 | $13.93M | Series B | – | – | – |
| Nov 2022 | $618,177 | Debt – Conventional | – | – | – |
| Jul 2021 | $99,240 | Series A | – | – | – |
| Jun 2020 | $587,465 | Series A | – | – | – |
| Apr 2019 | $997,991 | Grant | – | – | |
| Feb 2019 | $93,817 | Series A | – | – | – |
| Feb 2018 | $1.4M | Series A | – | – | – |
| Apr 2017 | $149,425 | Grant | – | – | |
| Nov 2016 | $749,986 | Series A | – | – | – |
3 investors in total: 3 institutional.
Investors in PECA Labs
PECA Labs has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include HHS, Innovation Works and BlueTree Allied Angels.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Software, hardware, and life sciences startups are funded and accelerated. | 1999 | innovationworks.org | Pittsburgh, United States | |
Public health and human services are overseen by HHS. | 1953 | hhs.gov | - | |
- | – | bluetreealliedangels.com | - |
Investor details for PECA Labs
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of PECA Labs
5 people are tracked at PECA Labs (3 in leadership, 2 in team).
| Name | Role | Group |
|---|---|---|
Doug Bernstein | Founder/CEO | Leadership |
Arush Kalra | Co-Founder/Chief Scientific Officer | Leadership |
Jamie Quinterno | Co-Founder and Chief Operating Officer | Leadership |
Blue Martin, PhD | Senior Research Engineer | Team |
Dharani A. | Regulatory Affairs Specialist | Team |
Complete people profiles for PECA Labs
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of PECA Labs
3 dated milestones of PECA Labs across 14 years, from founding to its latest funding, stage changes and deals.
- Founded PECA Labs is founded.
- Funding First funding round of $250K.
- Funding Latest funding round, Series B, of $2.7M.
Competitors of PECA Labs
PECA Labs has 8 listed competitors in our database, 7 of them funded. They include Xeltis, Occlutech, Endonovo Therapeutics, Bolder Surgical and Coherex, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| xeltis.com | 2006 | Zurich, Switzerland | $164.42M | – | Developer of bioabsorbable synthetic heart valves and vascular grafts | |
| occlutech.com | 2003 | Schaffhausen, Switzerland | $70.81M | – | Provider of minimally invasive cardiac devices for congenital heart defects, stroke prevention and heart failure | |
| endonovo.com | 2011 | Los Angeles, United States | – | – | Bioelectronic devices are developed for regenerative medicine therapies. | |
| boldersurgical.com | 2010 | Louisville, United States | $58.87M | – | Developer of electrosurgical device for pediatric patients | |
| coherex.com | 2003 | Salt Lake, United States | $25.03M | 19 | Structural heart disease conditions are addressed with implant devices. | |
| starlightcardio.com | 2020 | San Diego, United States | $9.48M | 8 | Devices for treating pediatric congenital heart defects are manufactured. | |
| polyvascular.com | 2014 | Houston, United States | $795,000 | – | Polymeric transcatheter valves are developed for congenital heart disease treatment. | |
| coaptus.com | 2003 | Redmond, United States | $3M | 40 | Develops non-implant therapeutics for treating patent foramen ovale, a structural heart defect. |
Detailed competitors of PECA Labs
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of PECA Labs
Websites that share an audience with PECA Labs (pecalabs.com).
Websites whose visitors overlap most with PECA Labs. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| arielmedicine.com | 100% | 1.3K | #10,684,349 | View details | |
| peptilogics.com | 97% | 2.1K | #8,263,579 | View details | |
| bluespherebio.com | 95% | 2.5K | #6,529,430 | View details | |
| plexision.com | 93% | 3.2K | #5,846,553 | View details | |
| ecmtherapeutics.com | 93% | 2.6K | #6,640,901 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 12 similar websites and full traffic analytics for PECA Labs
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 12 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Pediatrics
10 companies that operate in the same segment as PECA Labs (Pediatrics), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Owlet is recognized for developing FDA-cleared smart baby monitors. | 2013 | Lehi, Utah, United States | USD 54.96 M | USD 105.71 M | 85 | |
Therapeutics for gastrointestinal disorders, including linaclotide, are developed. | 1998 | Cambridge, Massachusetts, United States | USD 206.25 M | USD 296.15 M | 253 | |
Smart baby monitors and sleep tracking solutions are provided. | 2014 | New York, New York, United States | USD 116.6 M | – | – | |
Provider of diagnostic products for pediatrics | 2013 | Durham, North Carolina, United States | USD 95.89 M | – | – | |
Eye-tracking solutions for vision assessment and treatment are provided. | 2016 | Lod, Central District, Israel | USD 8 M | – | – | |
Patient vital signs are monitored via wearable devices and software. | 2018 | Niles, Illinois, United States | USD 71 M | – | – | |
Pediatric orthopedic devices are developed for surgical applications. | 2006 | Warsaw, United States | USD 51.55 M | USD 236.35 M | 562 | |
Gene therapy platform for rare disease treatments is developed. | 2018 | Exton, Pennsylvania, United States | USD 192.8 M | – | 41 | |
Drug-delivery platforms for pediatric wart treatments are developed. | 2020 | San Antonio, Texas, United States | USD 262.71 M | – | – | |
Online genetic engineering tools for drug development are provided. | 2020 | Philadelphia, Pennsylvania, United States | USD 115 M | – | 7 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Peca Labs
Complete news archive for PECA Labs
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about PECA Labs
PECA Labs was founded in 2011 and raised its 1st funding round 2 years after it was founded.
PECA Labs is headquartered in Pittsburgh, United States. It is registered at Pittsburgh, Pennsylvania, United States.
PECA Labs is a funded company, having raised a total of $22.56M across 12 funding rounds to date. The company's 1st funding round was a Series A of $749.99K, raised on Aug 2013.
PECA Labs was founded in 2011 and is based in Pittsburgh, United States. Focus is placed on the medical device sector, specifically pediatric cardiology. Operations involve the creation of synthetic valved conduits, such as the MASA valve made from ePTFE for right ventricular outflow tract reconstruction. A valved RV-PA shunt is also under development to treat hypoplastic left heart syndrome and mitigate risks associated with the Norwood Procedure.
PECA Labs's top competitors include Xeltis, Bolder Surgical and Endonovo Therapeutics.
PECA Labs offers exGraft, exGraft II, OKAPI, MASA Valve, and STEALTH.
PECA Labs has 3 investors. Key investors include HHS, Innovation Works, and BlueTree Allied Angels.
PECA Labs operates through Peca Labs, Inc..